228 related articles for article (PubMed ID: 7748321)
21. Flumazenil selectively prevents the increase in alpha(4)-subunit gene expression and an associated change in GABA(A) receptor function induced by ethanol withdrawal.
Biggio F; Gorini G; Caria S; Murru L; Sanna E; Follesa P
J Neurochem; 2007 Aug; 102(3):657-66. PubMed ID: 17403139
[TBL] [Abstract][Full Text] [Related]
22. Enhanced ultrasonic vocalization and Fos protein expression following ethanol withdrawal: effects of flumazenil.
Moy SS; Knapp DJ; Duncan GE; Breese GR
Psychopharmacology (Berl); 2000 Oct; 152(2):208-15. PubMed ID: 11057525
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms.
Anton RF; Myrick H; Baros AM; Latham PK; Randall PK; Wright TM; Stewart SH; Waid R; Malcolm R
J Clin Psychopharmacol; 2009 Aug; 29(4):334-42. PubMed ID: 19593171
[TBL] [Abstract][Full Text] [Related]
24. Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.
Gann H; Feige B; Cloot O; Van Wasen H; Zinzgraf D; Hohagen F; Riemann D
Pharmacopsychiatry; 2004 Sep; 37(5):228-35. PubMed ID: 15359376
[TBL] [Abstract][Full Text] [Related]
25. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
[TBL] [Abstract][Full Text] [Related]
26. Effects of flumazenil in the treatment of benzodiazepine withdrawal--a double-blind pilot study.
Saxon L; Hjemdahl P; Hiltunen AJ; Borg S
Psychopharmacology (Berl); 1997 May; 131(2):153-60. PubMed ID: 9201803
[TBL] [Abstract][Full Text] [Related]
27. Acupuncture in the treatment of alcohol withdrawal symptoms: a randomized, placebo-controlled inpatient study.
Karst M; Passie T; Friedrich S; Wiese B; Schneider U
Addict Biol; 2002 Oct; 7(4):415-9. PubMed ID: 14578018
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
Lemoine P; Touchon J; Billardon M
Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
[TBL] [Abstract][Full Text] [Related]
29. The benzodiazepine antagonist Ro 15-1788 does not antagonize the ethanol withdrawal syndrome.
Adinoff B; Majchrowicz E; Martin PR; Linnoila M
Biol Psychiatry; 1986 Jun; 21(7):643-9. PubMed ID: 3011130
[TBL] [Abstract][Full Text] [Related]
30. The role of beta blockers in alcohol withdrawal syndrome.
Gottlieb LD
Postgrad Med; 1988 Feb; Spec No():169-74. PubMed ID: 2894658
[TBL] [Abstract][Full Text] [Related]
31. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
Prather PL; Rezazadeh SM; Lane JD; Rowan GA; Hooper ML; Lytle DA; Emmett-Oglesby MW; Lal H
J Pharmacol Exp Ther; 1993 Feb; 264(2):622-30. PubMed ID: 8094750
[TBL] [Abstract][Full Text] [Related]
32. Multidimensionality of the Alcohol Withdrawal Symptom Checklist: a factor analysis of the Alcohol Withdrawal Symptom Checklist and CIWA-Ar.
Pittman B; Gueorguieva R; Krupitsky E; Rudenko AA; Flannery BA; Krystal JH
Alcohol Clin Exp Res; 2007 Apr; 31(4):612-8. PubMed ID: 17374040
[TBL] [Abstract][Full Text] [Related]
33. Effect of flumazenil-augmentation on microsleep and mood in depressed patients during partial sleep deprivation.
Hemmeter U; Hatzinger M; Brand S; Holsboer-Trachsler E
J Psychiatr Res; 2007 Nov; 41(10):876-84. PubMed ID: 16978648
[TBL] [Abstract][Full Text] [Related]
34. Double-blind controlled trial of bromocriptine, chlordiazepoxide and chlormethiazole for alcohol withdrawal symptoms.
Burroughs AK; Morgan MY; Sherlock S
Alcohol Alcohol; 1985; 20(3):263-71. PubMed ID: 3902038
[TBL] [Abstract][Full Text] [Related]
35. Alcohol withdrawal and flumazenil: not for the faint of heart.
Nelson LS
J Med Toxicol; 2014 Jun; 10(2):123-5. PubMed ID: 24595919
[No Abstract] [Full Text] [Related]
36. Benzodiazepine withdrawal: behavioural pharmacology and neurochemical changes.
File SE; Andrews N
Biochem Soc Symp; 1993; 59():97-106. PubMed ID: 7910743
[TBL] [Abstract][Full Text] [Related]
37. Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome.
Lemoine P; Kermadi I; Garcia-Acosta S; Garay RP; Dib M
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):131-7. PubMed ID: 16243418
[TBL] [Abstract][Full Text] [Related]
38. Tiapride and chlordiazepoxide in acute alcohol withdrawal. A controlled clinical trial.
Lepola U; Kokko S; Nuutila J; Gordin A
Int J Clin Pharmacol Res; 1984; 4(5):321-6. PubMed ID: 6394514
[TBL] [Abstract][Full Text] [Related]
39. Slight improvement in mood and irritability after antiepileptic drug withdrawal: a controlled study in patients on monotherapy.
Hessen E; Lossius MI; Reinvang I; Gjerstad L
Epilepsy Behav; 2007 May; 10(3):449-55. PubMed ID: 17350342
[TBL] [Abstract][Full Text] [Related]
40. The benzodiazepines: anxiolytic and withdrawal effects.
Little HJ
Neuropeptides; 1991 Jul; 19 Suppl():11-4. PubMed ID: 1679209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
